O
Ossiam’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $376K | Hold |
2,989
| – | – | ﹤0.01% | 496 |
|
|
2025
Q1 | $331K | Sell |
2,989
-496
| -14% | -$54.9K | ﹤0.01% | 465 |
|
|
2024
Q4 | $476K | Buy |
3,485
+484
| +16% | +$66.1K | 0.01% | 462 |
|
|
2024
Q3 | $346K | Buy |
3,001
+2,912
| +3,272% | +$336K | 0.01% | 494 |
|
|
2024
Q2 | $12.3K | Buy |
+89
| New | +$12.3K | ﹤0.01% | 611 |
|
|
2024
Q1 | – | Sell |
-5,376
| Closed | -$708K | – | 665 |
|
|
2023
Q4 | $708K | Buy |
5,376
+614
| +13% | +$80.9K | 0.01% | 417 |
|
|
2023
Q3 | $536K | Buy |
4,762
+1,579
| +50% | +$178K | 0.01% | 455 |
|
|
2023
Q2 | $300K | Buy |
3,183
+1,834
| +136% | +$173K | 0.01% | 531 |
|
|
2023
Q1 | $137K | Buy |
1,349
+603
| +81% | +$61K | ﹤0.01% | 542 |
|
|
2022
Q4 | $89.1K | Hold |
746
| – | – | ﹤0.01% | 597 |
|
|
2022
Q3 | $79K | Buy |
+746
| New | +$79K | ﹤0.01% | 624 |
|